ICD-10-PCS 2027 procedure code
0DU14KZSupplement Upper Esophagus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Short description: Supplement Up Esophag with Nonaut Sub, Perc Endo Approach
Code unchanged since ICD-10-PCS took effect on October 1, 2015. Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data
About 0DU14KZ
0DU14KZ is the ICD-10-PCS code for a supplement procedure on the esophagus, upper using a percutaneous endoscopic approach with nonautologous tissue substitute. In ICD-10-PCS, supplement means putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part.
In plain terms, this corresponds to other graft of esophagus, the ICD-9-CM procedure title it maps to (42.87).
For a different body part, codes include 0DU24KZ (esophagus, middle), 0DU34KZ (esophagus, lower), 0DU44KZ (esophagogastric junction), 0DU54KZ (esophagus), 0DU64KZ (stomach), 0DU74KZ (stomach, pylorus) and 19 more.
The same procedure with a different approach is coded 0DU10KZ (open), 0DU17KZ (via natural or artificial opening) and 0DU18KZ (via natural or artificial opening endoscopic).
With a different device, use 0DU147Z (autologous tissue substitute) and 0DU14JZ (synthetic substitute).
It is an operating-room procedure in the MS-DRG logic for DRG 143 (Other Ear, Nose, Mouth and Throat O.R. Procedures with MCC), DRG 144 (Other Ear, Nose, Mouth and Throat O.R. Procedures with CC), DRG 145 (Other Ear, Nose, Mouth and Throat O.R. Procedures without CC/MCC), DRG 326 (Stomach, Esophageal and Duodenal Procedures with MCC), DRG 327 (Stomach, Esophageal and Duodenal Procedures with CC) and DRG 328 (Stomach, Esophageal and Duodenal Procedures without CC/MCC), under the surgical categories “Other Ear, Nose, Mouth and Throat O.R. Procedures”, “Stomach, Esophageal and Duodenal Procedures”, “Lymphoma and Leukemia with Major O.R. Procedures” and 3 more.
It has been valid since ICD-10-PCS took effect on October 1, 2015.
What each character means
- 1. Section
- 0Medical and Surgical
- 2. Body System
- DGastrointestinal System
- 3. Operation
- USupplement
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
The biological material is non-living, or is living and from the same individual. The body part may have been previously replaced, and the Supplement procedure is performed to physically reinforce and/or augment the function of the replaced body part
Includes: Herniorrhaphy using mesh, mitral valve ring annuloplasty, put a new acetabular liner in a previous hip replacement
- 4. Body Part
- 1Esophagus, Upper
Includes: Cervical esophagus
- 5. Approach
- 4Percutaneous Endoscopic
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach and visualize the site of the procedure
- 6. Device
- KNonautologous Tissue Substitute
Includes: Acellular Hydrated Dermis; Bone bank bone graft; Cook Biodesign(R) Fistula Plug(s); Cook Biodesign(R) Hernia Graft(s); Cook Biodesign(R) Layered Graft(s); Cook Zenapro(tm) Layered Graft(s); Fish skin; Kerecis(R) (GraftGuide) (MariGen) (SurgiBind) (SurgiClose); MIRODERM(tm) Biologic Wound Matrix; Piscine skin; Tissue bank graft
- 7. Qualifier
- ZNo Qualifier
Other versions of this procedure
Different body part
Different approach
Different device
MS-DRG v44.0 grouping
All DRGs →Surgical MS-DRGs this procedure can group to, depending on the principal diagnosis's MDC.
MDC 03 · Diseases and Disorders of the Ear, Nose, Mouth and Throat · Other Ear, Nose, Mouth and Throat O.R. Procedures
MDC 06 · Diseases and Disorders of the Digestive System · Stomach, Esophageal and Duodenal Procedures
MDC 17 · Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms · Lymphoma and Leukemia with Major O.R. Procedures
MDC 17 · Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms · Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures
- 826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCCRW 4.7581
- 827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CCRW 2.3896
- 828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCCRW 1.6955
MDC 21 · Injuries, Poisonings and Toxic Effects of Drugs · Other O.R. Procedures for Injuries
MDC 24 · Multiple Significant Trauma · Other O.R. Procedures for Multiple Significant Trauma
ICD-9-CM equivalent
Converter →- 42.87Other graft of esophagusapproximate
From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about 0DU14KZ
Is 0DU14KZ a valid ICD-10-PCS code for 2027?
- Yes. 0DU14KZ is valid for inpatient procedures from October 1, 2026 through September 30, 2027.
Is 0DU14KZ an O.R. procedure?
- Yes. 0DU14KZ is an O.R. procedure in MS-DRG v44.0.
What DRG does 0DU14KZ group to?
- Depending on the principal diagnosis, 0DU14KZ can group to MS-DRG 143, MS-DRG 144, MS-DRG 145, MS-DRG 326, MS-DRG 327 and MS-DRG 328.
What is the ICD-9 procedure code for 0DU14KZ?
- The CMS GEMs map 0DU14KZ to ICD-9-CM 42.87 (Other graft of esophagus).